Anti-microbial Resistance (AMR) is of growing global concern with England’s Chief Medical Officer, Dame Sally Davies recently describing it as a 'ticking time bomb'. Just recently, the UK Government’s National Risk Register of Civil Emergencies has published a report indicating that the number of infections complicated by AMR will rise significantly over the next 20 years, with even routine minor surgery and routine operations becoming high risk. The speakers at this event will set out their perspectives on the challenges and how emerging technologies are leading to innovative intervention strategies, and  Dr. Vicky Steadman will be giving a keynote presentation at this event entitled ‘A ‘game changing’ new antibiotic? The discovery of Teixobactin’.

For more information regarding Selcia’s integrated drug discovery offerings, including structural elucidation and lead optimisation of natural products please contact us through our website www.selcia.com.

For more information on the even please visit the One Nucelus website.